A study from United Kingdom has shown reduced expression of FHIT in a small proportion of colonic precancerous lesions and in increased proportions of primary and metastatic colorectal cancers suggesting that FHIT plays a role in the development and progression of some colon carcinomas [48]. Here, FHIT is linked to metastatic colorectal cancer.